{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:25:01Z","timestamp":1789205101780,"version":"build-2803163510"},"update-to":[{"DOI":"10.1016\/j.neuropharm.2014.07.012","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000}}],"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.neuropharm.2014.07.012","type":"journal-article","created":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T04:30:32Z","timestamp":1406781032000},"page":"192-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":163,"special_numbering":"C","title":["RETRACTED: Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice"],"prefix":"10.1016","volume":"86","author":[{"given":"Sachin P.","family":"Patil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj D.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayant S.","family":"Sancheti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya J.","family":"Ghumatkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufi","family":"Tambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhana","family":"Sathaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2014.07.012_bib1","first-page":"673","article-title":"Catalase","volume":"vol. 2","author":"Aebi","year":"1974"},{"key":"10.1016\/j.neuropharm.2014.07.012_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/891748","article-title":"Polyphenols: multipotent therapeutic agents in neurodegenerative diseases","author":"Bhullar","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/08977190410001723308","article-title":"Brain-derived neurotrophic factor","volume":"22","author":"Binder","year":"2004","journal-title":"Growth Factors"},{"key":"10.1016\/j.neuropharm.2014.07.012_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-1-62703-251-3_17","article-title":"The MPTP\/Probenecid model of progressive Parkinson's disease","volume":"964","author":"Carta","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib5","first-page":"1","article-title":"Motor coordination and balance in rodents","author":"Carter","year":"2001","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib6","first-page":"175","article-title":"Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation","volume":"448","author":"Chen","year":"2008"},{"key":"10.1016\/j.neuropharm.2014.07.012_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/646354","article-title":"Oxidative stress, mitochondrial dysfunction, and aging","author":"Cui","year":"2012","journal-title":"J.\u00a0Signal Transduct."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib8","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1097\/00001756-200112040-00053","article-title":"Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease","volume":"12","author":"Datla","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2014.07.012_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","article-title":"Tyrosine hydroxylase and regulation of dopamine synthesis","volume":"508","author":"Daubner","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1440-1789.1999.00196.x","article-title":"Tyrosine Hydroxylase-immunoreactive neurons are decreased in number in the cerebral cortex of Parkinson's disease","volume":"19","author":"Fukuda","year":"1999","journal-title":"Neuropathology"},{"key":"10.1016\/j.neuropharm.2014.07.012_bib11","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.intimp.2011.03.012","article-title":"Anti-inflammatory activity of structurally related flavonoids, Apigenin, Luteolin and Fisetin","volume":"11","author":"Funakoshi-Tago","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib12","first-page":"1","article-title":"Whole animal perfusion fixation for rodents","volume":"65","author":"Gage","year":"2012","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/370555a0","article-title":"Processing of tumour necrosis factor-alpha precursor by metalloproteinases","volume":"370","author":"Gearing","year":"1994","journal-title":"Lett. Nat."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-60761-303-9_1","article-title":"The open field test","volume":"42","author":"Gould","year":"2009","journal-title":"Neuromethods"},{"key":"10.1016\/j.neuropharm.2014.07.012_bib15","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1093\/ajcn\/57.5.715S","article-title":"Lipid peroxidation: its mechanism, measurement, and significance","volume":"57","author":"Halliwell","year":"1993","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.31887\/DCNS.2004.6.3\/ahartmann","article-title":"Postmortem studies in Parkinson's disease","volume":"6","author":"Hartmann","year":"2004","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib17","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1523\/JNEUROSCI.19-09-03440.1999","article-title":"FcqRII\/CD23 is expressed in Parkinson's disease and induces, in\u00a0vitro, production of nitric oxide and tumor necrosis factor-\u03b1 in glial cells","volume":"19","author":"Hunot","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.07.012_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1212\/WNL.47.6_Suppl_3.161S","article-title":"Oxidative stress and the pathogenesis of Parkinson's disease","volume":"47","author":"Jenner","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2014.07.012_bib21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/jnnp.54.8.679","article-title":"Glutathione peroxidase in early and advanced Parkinson's disease","volume":"54","author":"Johannsen","year":"1991","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.07.012_bib22","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1021\/jf204970r","article-title":"Improved pyrogallol autoxidation method: a reliable and cheap superoxide-scavenging assay suitable for all antioxidants","volume":"60","author":"Li","year":"2012","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.phrs.2008.03.004","article-title":"Bromocriptine activates NQO1 via Nrf2-PI3K\/Akt signaling: novel cytoprotective mechanism against oxidative damage","volume":"57","author":"Lim","year":"2008","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ajcn\/79.5.727","article-title":"Polyphenols: food sources and bioavailability","volume":"79","author":"Manach","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ncpneuro0355","article-title":"Mechanisms of Disease: astrocytes in neurodegenerative Disease","volume":"2","author":"Maragakis","year":"2006","journal-title":"Nat. Clin. Practice:Neurol."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00702-009-0194-0","article-title":"Alterations of oxidative stress markers and apoptosis markers in the striatum after transient focal cerebral ischemia in rats","volume":"116","author":"Matsuda","year":"2009","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nrd3430","article-title":"Priorities in Parkinson's disease research","volume":"10","author":"Meissner","year":"2011","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-4-431-53945-2_2","article-title":"Adult neurogenesis in Parkinson's disease","author":"Mochizuki","year":"2011","journal-title":"Neurogenesis Adult Brain II"},{"key":"10.1016\/j.neuropharm.2014.07.012_bib29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.neuroscience.2004.11.056","article-title":"Platelet-derived growth factor (PDGF-BB) and brain-derived neurotrophic factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions","volume":"132","author":"Mohapel","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.07.012_bib30","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.neuroscience.2005.07.060","article-title":"Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration","volume":"138","author":"Morale","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.07.012_bib31","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1096\/fasebj.12.10.905","article-title":"Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice","volume":"12","author":"Muralikrishnan","year":"1998","journal-title":"FASEB"},{"key":"10.1016\/j.neuropharm.2014.07.012_bib32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF02712155","article-title":"Assay of superoxide dismutase activity in animal tissues","volume":"13","author":"Nandi","year":"1988","journal-title":"J.\u00a0Biosci."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib34","first-page":"1","article-title":"Mitochondrial biology and Parkinson's disease","volume":"4","author":"Perier","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1566-2772(01)00019-6","article-title":"MPTP: a review of its mechanisms of neurotoxicity","volume":"1","author":"Przedborski","year":"2001","journal-title":"Clin. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib36","first-page":"1","article-title":"Measurement of lipid peroxidation","author":"Reilly","year":"1999","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-5-41","article-title":"Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression","volume":"5","author":"Rezai-Zadeh","year":"2008","journal-title":"J.\u00a0Neuroinflam."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00702-007-0860-z","article-title":"Time dependent changes of striatal interneurons after focal cerebral ischemia","volume":"115","author":"Sakuma","year":"2008","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib39","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0091-3057(97)00054-3","article-title":"Anxiolytic natural and synthetic flavonoids ligands of the central benzodiazepine receptor have no effect on memory tasks in rats","volume":"58","author":"Salgueiro","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib40","first-page":"351","article-title":"Estimation of total and non-protein sulfydral groups in tissues with Ellman's reagent","volume":"95","author":"Sedlak","year":"1968","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib41","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s007020170003","article-title":"Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients","volume":"108","author":"Serra","year":"2001","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib42","first-page":"790","article-title":"Protective effect of apigenin in transgenic Drosophila Melanogaster model of Parkinson's disease","volume":"3","author":"Siddique","year":"2011","journal-title":"Pharmacologyonline"},{"key":"10.1016\/j.neuropharm.2014.07.012_bib43","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0003-2697(72)90132-7","article-title":"Calorimetric assay of catalase","volume":"47","author":"Sinha","year":"1972","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib44","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0003-2697(88)90564-7","article-title":"Assay of glutathione reductase in crude tissue homogenates using 5,5'-dithiobis(2-nitrobenzoic acid)","volume":"175","author":"Smith","year":"1988","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib45","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1517\/13543770902721279","article-title":"Apigenin and related compounds stimulate adult neurogenesis","volume":"19","author":"Taupin","year":"2009","journal-title":"Expert Opin. Ther. Patents"},{"key":"10.1016\/j.neuropharm.2014.07.012_bib46","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neuint.2012.12.016","article-title":"Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson's disease","volume":"62","author":"Taylor","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib47","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2174\/156720507781788873","article-title":"TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets","volume":"4","author":"Tweedie","year":"2007","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-2006-958058","article-title":"Apigenin, a component of Matricaria recutitaflowers, is a central benzodiazepine receptors-ligand with anxiolytic effects","volume":"61","author":"Viola","year":"1995","journal-title":"Planta Med."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2047-9158-1-14","article-title":"Current advances in using neurotrophic factors to treat neurodegenerative disorders","volume":"1","author":"Weissmiller","year":"2012","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nprot.2009.197","article-title":"Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue","volume":"5","author":"Weydert","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib51","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","article-title":"Inflammation as a causative factor in the aetiology of Parkinson's disease","volume":"150","author":"Whitton","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib52","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1471-4159.2003.01652.x","article-title":"Interaction between flavonoids and the blood\u2013brain barrier: in\u00a0vitro studies","volume":"85","author":"Youdim","year":"2003","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib53","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.freeradbiomed.2003.11.023","article-title":"Flavonoid permeability across an in situ model of the blood\u2013brain barrier","volume":"36","author":"Youdim","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2014.07.012_bib54","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0002-9440(10)65396-5","article-title":"Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons","volume":"154","author":"Zhang","year":"1999","journal-title":"Am. J. Pathol."}],"updated-by":[{"DOI":"10.1016\/j.neuropharm.2021.108876","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"record-id":"33941"},{"DOI":"10.1016\/j.neuropharm.2021.108876","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000}},{"DOI":"10.1016\/j.neuropharm.2014.07.012","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000}}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814002743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814002743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:47:13Z","timestamp":1758437233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390814002743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":54,"alternative-id":["S0028390814002743"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.07.012","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}